Jul. 2 at 7:32 PM
Profitable as of Q3 2025, Precipio (Nasdaq:
$PRPO ) has canceled its ATM facility to move away from the dilutive capital raises common among microcap companies.
Precipio, Inc. (Nasdaq: PRPO) did something uncommon for a microcap diagnostics company: it turned profitable, hitting that mark in the third quarter of 2025 and canceling the at-the-market facility it once leaned on. CEO Ilan Danieli framed the shift for microcap investors as a deliberate move toward financial independence.
Precipio is a B2i Digital Featured Company. See the company's profile at b2idigital.com/precipio-inc-1 and follow Precipio on X, LinkedIn, and Facebook.
"One of the most important things for us as a company to achieve in 2025 was to become profitable," said Danieli. "A couple years ago we did a capital raise. It wasn't the prettiest one, and our team sat around and said, that's it, we're done, we're not doing anything more. We're going to become financially independent. And we did. So we are profitable as of Q3 of 2025."
Elsewhere in the session, Danieli covered:
• That Precipio canceled its at-the-market (ATM) facility, a signal to shareholders that it would stop the dilutive financing many microcaps rely on
• How a cash-efficient model lets the company fund new products without raising another
$5 million and diluting investors each time
• Why he believes operating profitably at the company's current scale makes for an attractive long-term business model
Precipio is a healthcare biotechnology company focused on cancer diagnostics. Its mission is to address the problem of cancer misdiagnoses by developing diagnostic products and services designed to deliver greater accuracy, improved laboratory workflow, and better patient outcomes. Precipio develops, validates, and clinically uses these technologies in its laboratory before commercializing them as proprietary products for the global laboratory community. More information is at precipiodx.com. Investor inquiries:
[email protected], +1-203-787-7888 Ext. 523.
Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com.
Disclosure: This post is informational only and is not an offer or solicitation regarding any security. See the complete Disclosure at b2idigital.com/disclaimer. B2i Digital is not a broker-dealer or investment adviser.
$EXAS,
$NTRA,
$GH,
$XBI